We recently published a list of the 15 Best Dividend Aristocrat Stocks with Over 3% Yield. In this article, we are going to ...
We recently published a list of Jim Cramer Says Trump’s Tariff Strategy Is Working & Discusses These 11 Stocks. In this ...
Now that the JNJ stock has seen a 7% fall, does the current price point make it attractive? Going by what you pay per dollar ...
Johnson & Johnson's Phase 3b APEX study shows Tremfya reduces symptoms and structural damage in psoriatic arthritis patients ...
“Investors can gain exposure to the healthcare sector by owning the S&P 500 through a passively managed index fund or ETF.
Johnson & Johnson updates its $14.2B acquisition timeline of Intra-Cellular Therapies, boosting 2025 sales but slightly ...
Johnson & Johnson (NYSE:JNJ – Get Free Report)‘s stock had its “neutral” rating reaffirmed by analysts at Guggenheim in a ...
In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Hold rating on Johnson & Johnson (JNJ – Research Report), ...
Johnson & Johnson's long-term prospects are promising due to strong drug pipeline developments and significant R&D ...
Johnson & Johnson (NYSE:JNJ – Get Free Report)‘s stock had its “outperform” rating reaffirmed by Royal Bank of Canada in a research note issued on Wednesday,Benzinga reports. They currently have a ...
Johnson & Johnson shares tumbled Tuesday to lead S&P 500 decliners after the health care giant failed to reach a settlement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results